[HTML][HTML] Advances in immunotherapy for MMR proficient colorectal cancer
H Lote, N Starling, R Pihlak, M Gerlinger - Cancer treatment reviews, 2022 - Elsevier
Survival in mismatch-repair proficient (MMRp) metastatic colorectal cancer (mCRC) remains
poor and chemotherapy is the mainstay of treatment. Immunotherapy has demonstrated …
poor and chemotherapy is the mainstay of treatment. Immunotherapy has demonstrated …
[HTML][HTML] Recent advances in rectal cancer treatment–are we on the right track?
B Glimelius - Upsala Journal of Medical Sciences, 2024 - ncbi.nlm.nih.gov
Background Staging and treatment of rectal cancer have evolved over several decades with
considerably fewer locoregional recurrences but no marked improved survival since …
considerably fewer locoregional recurrences but no marked improved survival since …
New Opportunities for Minimizing Toxicity in Rectal Cancer Management
AM Couwenberg, DN Varvoglis, BC Grieb… - American Society of …, 2023 - ascopubs.org
Advances in multimodal management of locally advanced rectal cancer (LARC), consisting
of preoperative chemotherapy and/or radiotherapy followed by surgery with or without …
of preoperative chemotherapy and/or radiotherapy followed by surgery with or without …
Current Surgical Methods in Local Rectal Excision
K Šemanjski, K Lužaić, J Brkić - Gastrointestinal Tumors, 2023 - karger.com
Background: The treatment of rectal cancer has evolved with the advancement of surgical
techniques. Less invasive approaches are becoming more accepted as the primary …
techniques. Less invasive approaches are becoming more accepted as the primary …
Editorial for Special Issue “Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract”
G Masi - Cancers, 2023 - mdpi.com
After transforming the therapeutic perspective of many solid neoplasms, immunotherapy is
finally making its way in the setting of gastro-intestinal (GI) primary cancers. Both …
finally making its way in the setting of gastro-intestinal (GI) primary cancers. Both …
Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Lung …
X Cao, F Yang, S Jiang, K Deng, Y Dong, J Wei… - 2023 - researchsquare.com
Background: Cancer-associated fibroblasts (CAFs) are vital in tumorigenesis, metastasis,
and response to therapy. This study aimed to explore the characteristics of CAFs in lung …
and response to therapy. This study aimed to explore the characteristics of CAFs in lung …
[PDF][PDF] Editorial for Special Issue “Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract”. Cancers 2023, 15, 1223
G Masi - 2023 - arpi.unipi.it
After transforming the therapeutic perspective of many solid neoplasms, immunotherapy is
finally making its way in the setting of gastro-intestinal (GI) primary cancers. Both …
finally making its way in the setting of gastro-intestinal (GI) primary cancers. Both …